Evidence map›Paper›PMID 31004204›Full record

ArticleWorld journal of urology2020

Evaluation of the draft guidelines proposed by EMA and FDA for the clinical diagnosis of acute uncomplicated cystitis in women.

Jakhongir F Alidjanov, Kurt G Naber, Adrian Pilatz, Abdukhamid Radzhabov, Musluhuddin Zamuddinov, András Magyar, Peter Tenke, Florian M Wagenlehner

Abstract readMulticenter Study
In one paragraph

Article in World journal of urology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Effects of a supplement associatingInvestigative and clinical urology · 2025
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Recent research in urological infections.Nature reviews. Urology · 2020
    Article
  19. Urogenital infections.World journal of urology · 2020
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jakhongir F AlidjanovDepartment of Urology, Pediatric Urology and Andrology, Justus-Liebig-University, Rudolph-Buchheim Str.7, 35392, Giessen, Germany. dr.alidjanov@gmail.com.ORCID http://orcid.org/0000-0003-2531-4877
Kurt G Naber, Straubing, Germany.ORCID http://orcid.org/0000-0003-1304-5403
Adrian PilatzDepartment of Urology, Pediatric Urology and Andrology, Justus-Liebig-University, Rudolph-Buchheim Str.7, 35392, Giessen, Germany.ORCID http://orcid.org/0000-0001-8072-1841
Abdukhamid RadzhabovTreatment and Diagnostic Center "Olami Tib", J.Rasulov 29 Street., 734060, Dushanbe, Tajikistan.ORCID http://orcid.org/0000-0003-1948-5792
Musluhuddin ZamuddinovDepartment of Urology, Madadi Akbar Clinic, Ayni Street 14, Dushanbe, Tajikistan.
András MagyarDepartment of Urology, Jahn Ferenc South Pest Teaching Hospital, Köves út 1, Budapest, 1204, Hungary.ORCID http://orcid.org/0000-0002-0299-5529
Peter TenkeDepartment of Urology, Jahn Ferenc South Pest Teaching Hospital, Köves út 1, Budapest, 1204, Hungary.ORCID http://orcid.org/0000-0002-1081-4011
Florian M WagenlehnerDepartment of Urology, Pediatric Urology and Andrology, Justus-Liebig-University, Rudolph-Buchheim Str.7, 35392, Giessen, Germany.ORCID http://orcid.org/0000-0002-2909-0797

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo reassess the diagnostic values of the "draft" guidelines for the clinical diagnosis of acute uncomplicated cystitis (AC), recently proposed by US Food and Drug Administration (FDA) and European Medicines Agency (EMA).

methodsThe data of 517 female respondents (patients with acute cystitis and controls) derived from the e-USQOLAT database were analyzed and used for the validation of proposed "draft" guidelines of FDA and EMA, compared to the Acute Cystitis Symptom Score (ACSS) questionnaire. The diagnostic values of the proposals concerning signs, symptoms and their severity were assessed and compared.

resultsThe six "typical" symptoms of the ACSS were strongly associated with the diagnosis of AC. The number of positive "typical" symptoms differed significantly between patients and controls: median 5 (IQR 4-6) vs 1 (IQR 0-3) respectively. Scored severity of "typical" symptoms also differed significantly between groups of patients and controls: median (IQR) 10 (7-13) vs 1 (0-4), respectively. The best balance between sensitivity and specificity is shown by the ACSS cut-off value of 6 scores and more of the "Typical" domain, followed by an approach proposed by FDA and EMA, justifying ACSS to be used as a diagnostic criterion for the clinical diagnosis of AC.

conclusionsNot only the presence but also the severity of the symptoms is important for an accurate diagnosis of AC. The ACSS, even without urinalysis is at least as favourable as the draft diagnostic proposals by FDA and EMA. The ACSS can be recommended for epidemiological and interventional studies, and allows women to establish self-diagnosis of AC, making the ACSS also cost-effective for healthcare.

Indexed as

Guidelines as TopicSocieties, MedicalUnited States Food and Drug AdministrationAcute DiseaseAdolescentAdultAgedAged, 80 and overCystitisDiagnosis, DifferentialEuropeFemaleFollow-Up StudiesHumansMiddle AgedRetrospective StudiesACSSAcute Cystitis Symptom ScoreCystitisDiagnosisGuidelinesUrinary tract infection

Identifiers

PMID31004204
PMCPMC6954149

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.